CCN2 and metabolic dysfunction-associated steatohepatitis: Hepatic levels of mRNA for cell communication network factor 3 (CCN3), which is often expressed reciprocally to and is an antagonist of CCN2 [74,75], was suppressed in the NASH model, and this was reversed by CCN2 antibody administration [73].